icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
Interactions Between ABT-493 plus ABT-530 combination and Rilpivirine or Raltegravir
 
 
  Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
 
*Rajneet K. Oberoi1, *Matthew P. Kosloski1, Bifeng Ding1, Beibei Hu1, Stanley Wang1, Jens Kort1, Sandeep Dutta1, Wei Liu1 *Contributed equally to the abstract 1AbbVie Inc., North Chicago, Illinois, United States

CROI1

CROI2

CROI3

CROI4

CROI5